Some hip symptoms need prompt medical care

A fall needs quick care when you can't stand

If standing isn't possible after a fall, call for medical help. A shorter-looking or twisted leg needs care now. Don't test it by taking more steps.

A first X-ray can miss a small break. Call your doctor again if groin pain continues. Call again when walking stays hard too.

Tell the doctor how you fell. Say whether you hit the ground. Mention blood thinners and any new bruising. Don't leave those details out.

Fever and new weakness can't wait

Seek urgent medical care when fever comes with hip heat and swelling. Feeling very ill makes this more pressing. Don't wait for a planned clinic visit.

New numbness or weakness also needs quick care. Get help now if bladder or bowel control stops. Nerves from your back may be involved.

Call your doctor soon when no position eases night pain. Do the same after weight loss you didn't plan. Mention any cancer history during that call.

A slow ache can start with a regular visit

Soreness that grew slowly is often less urgent. Book an exam when it limits walking or sleep. Bring your medicine list and any old X-ray.

Until then, shorten tasks that make it flare. Keep moving gently when that feels safe. You don't need to test your limit.

Write down each new warning sign. Don't wait for the booked visit if one starts. Note the time, sore spot, and activity. When doctors have cleared urgent trouble, QC Kinetix can examine the soreness and discuss regenerative treatments made at the clinic from your blood or bone marrow.

Sources

1. Among 179 patients (mean age 82) presenting with hip pain and NORMAL plain radiographs, further imaging revealed an occult hip fracture in 71 and a pelvic or acetabular fracture in 34. The authors advocate a high index of suspicion and early imaging for older patients with non-specific hip pain after a fall - a normal x-ray does not rule out a fracture.

   Rehman H, et al. — Imaging of occult hip fractures: CT or MRI?. Injury, 2016. DOI: 10.1016/j.injury.2016.02.020.

2. The 2026 Cochrane update of exercise for hip osteoarthritis (18 trials, 1368 participants) found that against attention control or placebo, exercise may have little to no effect on pain (MD -6.31 points on 0-100, 95% CI -12.98 to 0.35, low certainty) and may improve physical function only slightly; against no treatment or usual care it probably reduces pain slightly (MD -7.19, 95% CI -10.70 to -3.68, moderate certainty) but the review states these improvements are unlikely to be clinically meaningful. This is a weaker result than the equivalent knee evidence and it must not be overstated.

   Hall M, et al. — Exercise for osteoarthritis of the hip.. Cochrane Database of Systematic Reviews, 2026. DOI: 10.1002/14651858.CD007912.pub3.

3. The AAOS evidence-based clinical practice guideline on Management of Osteoarthritis of the Hip states verbatim: STRONG evidence supports intra-articular corticosteroids to improve function and reduce pain in the SHORT TERM; STRONG evidence does NOT support intra-articular hyaluronic acid, because it does not perform better than placebo for function, stiffness and pain; STRONG evidence supports physical therapy for mild to moderate symptoms; STRONG evidence supports NSAIDs for short-term pain and function; and MODERATE evidence does not support glucosamine sulfate.

   American Academy of Orthopaedic Surgeons — Management of Osteoarthritis of the Hip: Evidence-Based Clinical Practice Guideline.. AAOS, 2017.

4. A Bayesian network meta-analysis of 11 randomized trials (1353 patients) in hip osteoarthritis found that at 2-4 months and 6 months NO injectable - corticosteroid, hyaluronic acid or platelet-rich plasma - significantly outperformed a saline placebo injection for pain or function. Pooled change from baseline exceeded the minimal clinically important difference in every arm including placebo.

   Gazendam A, et al. — Intra-articular saline injection is as effective as corticosteroids, platelet-rich plasma and hyaluronic acid for hip osteoarthritis pain: a systematic review and network meta-analysis of randomised controlled trials.. British Journal of Sports Medicine, 2021. DOI: 10.1136/bjsports-2020-102179.

5. FDA states plainly that no stem cell, exosome, stromal vascular fraction, umbilical cord blood, Wharton's jelly or amniotic-fluid product has been approved for the treatment of ANY orthopedic condition - it names osteoarthritis, tendonitis, disc disease, tennis elbow, back pain, hip pain, knee pain, neck pain and shoulder pain individually. The only FDA-approved stem cell products in the United States are cord-blood-derived blood-forming stem cells for disorders of the hematopoietic system, and there are currently no FDA-approved exosome products.

   US Food and Drug Administration, Center for Biologics Evaluation and Research — Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes. FDA, 2020.